{"transactions":[{"id":784907,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T19:21:46.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, vested in full on the grant date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001213900-26-054430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026054430/ownership.xml","form_type":"4"}},{"id":1968496,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:37:38.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":4.26,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10250},"source":{"system":"sec-edgar","filing":"0001209191-23-016164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919123016164/doc4.xml","form_type":"4"}},{"id":1968495,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:37:38.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":9.16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-016164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919123016164/doc4.xml","form_type":"4"}},{"id":1968494,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T11:37:38.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option that had a per share exercise price that was less than the Cash Amount (whether vested or unvested) that was outstanding and unexercised immediately prior to the Effective Time, was cancelled and converted into the right to receive, for each Share underlying such option, (i) an amount in cash equal to the excess of the Cash Amount over the per share exercise price of such option and (ii) one CVR. Each option that was outstanding and unexercised immediately prior to the Effective Time that had a per share exercise price greater than or equal to the Cash Amount, and less than $11.50, was cancelled and converted into the right to receive, for each Share underlying such option, upon the occurrence of any Milestone Payment, (i) an amount in cash equal to the Cash Amount, plus the applicable Milestone Payment, plus any Milestone Payment previously paid with respect to such Share, (continued in Footnote 5)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"minus the per share exercise price of the option, minus (ii) any amount previously paid out for such option pursuant to any previous Milestone Payment."}],"balance_after":0,"derivative":{"exercise_price":11.02,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-016164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919123016164/doc4.xml","form_type":"4"}},{"id":1968493,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T11:37:38.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":16400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This line item represents unvested time-based restricted stock units with respect to the Issuer's common stock (\"RSUs\") held by the Reporting Person. Pursuant to the terms of the Merger Agreement, at the Effective Time, each unvested RSU that was outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive, for each Share underlying such RSU, the Per Share Consideration, subject to withholding of applicable taxes and without interest."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This line item represents unvested time-based restricted stock units with respect to the Issuer's common stock (\"RSUs\") held by the Reporting Person. Pursuant to the terms of the Merger Agreement, at the Effective Time, each unvested RSU that was outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive, for each Share underlying such RSU, the Per Share Consideration, subject to withholding of applicable taxes and without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-016164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919123016164/doc4.xml","form_type":"4"}},{"id":1968492,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-06T11:37:38.000Z","date":"2023-03-06","kind":"other","acquired":false,"shares":5125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 19, 2023, by and among Concert Pharmaceuticals, Inc. (the \"Issuer\"), Sun Pharmaceutical Industries Ltd. (\"Parent\") and Foliage Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of March 6, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $8.00 in cash (the \"Cash Amount\"), plus one non-tradeable contingent value right (a \"CVR,\" and together with the Cash Amount, the \"Per Share Consideration\"), which represents the right to receive contingent payments of up to $3.50 per Share, in cash, (continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"in the aggregate, upon the achievement of certain milestones (such applicable payment, each, a \"Milestone Payment\") prior to December 31, 2029, subject to any applicable withholding of taxes and without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-016164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919123016164/doc4.xml","form_type":"4"}},{"id":2233777,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T16:14:26.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":16400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 9, 2023 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":21525,"source":{"system":"sec-edgar","filing":"0001209191-22-036286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919122036286/doc4.xml","form_type":"4"}},{"id":2671489,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T08:40:01.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 10, 2022, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 10, 2022)."}],"balance_after":10250,"derivative":{"exercise_price":4.26,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10250},"source":{"system":"sec-edgar","filing":"0001209191-21-039744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919121039744/doc4.xml","form_type":"4"}},{"id":2671488,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T08:40:01.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5125,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 10, 2022 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":5125,"source":{"system":"sec-edgar","filing":"0001209191-21-039744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919121039744/doc4.xml","form_type":"4"}},{"id":3111507,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T17:03:43.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period through June 11, 2021, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 11, 2021)."}],"balance_after":10000,"derivative":{"exercise_price":9.16,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-036346","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919120036346/doc4.xml","form_type":"4"}},{"id":3252768,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-24T17:56:20.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":107000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on February 20, 2021, and the remaining shares shall vest in substantially equal monthly installments over the following three years, subject to continued service with RDUS through such dates."}],"balance_after":107000,"derivative":{"exercise_price":19.96,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":107000},"source":{"system":"sec-edgar","filing":"0001209191-20-012148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919120012148/doc4.xml","form_type":"4"}},{"id":3487559,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2019-06-17T21:01:42.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a three-year period measured from the date of grant, subject to the Reporting Person's continued service as a director, and will become exercisable in full upon a change in control of the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":11.02,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-037560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367920/000120919119037560/doc4.xml","form_type":"4"}},{"id":3631895,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Stock Units","published_at":"2019-02-26T18:15:05.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":71000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. 50% of the restricted stock units shall vest upon the execution of a Board approved partnership for elacestrant within twelve months from the grant date of February 22, 2019, and, assuming such performance condition is achieved, the remaining restricted stock units shall vest on the third anniversary of the grant date of February 22, 2019, subject to continued service with RDUS through such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. 50% of the restricted stock units shall vest upon the execution of a Board approved partnership for elacestrant within twelve months from the grant date of February 22, 2019, and, assuming such performance condition is achieved, the remaining restricted stock units shall vest on the third anniversary of the grant date of February 22, 2019, subject to continued service with RDUS through such dates."}],"balance_after":71000,"derivative":{"expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":71000},"source":{"system":"sec-edgar","filing":"0001209191-19-013710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919119013710/doc4.xml","form_type":"4"}},{"id":3631894,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoeiland Jesper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-26T18:15:05.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":128000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on February 22, 2020, and the remaining shares shall vest in substantially equal monthly installments over the following three years, subject to continued service with RDUS through such dates."}],"balance_after":128000,"derivative":{"exercise_price":19.18,"expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0001209191-19-013710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919119013710/doc4.xml","form_type":"4"}},{"id":4054650,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoiland Jesper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-15T19:43:54.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on February 13, 2019 and the remaining shares shall vest in substantially equal monthly installments over the following three years."}],"balance_after":210000,"derivative":{"exercise_price":37.83,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001209191-18-010552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919118010552/doc4.xml","form_type":"4"}},{"id":4170096,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoiland Jesper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-07T17:14:45.000Z","date":"2017-11-07","kind":"purchase","acquired":true,"shares":6800,"price":29.0368,"value":197450.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were  purchased in multiple transactions at prices ranging from $29.0516 to $29.00, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares of Common Stock purchased at each separate price."}],"balance_after":12900,"source":{"system":"sec-edgar","filing":"0001209191-17-059635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919117059635/doc4.xml","form_type":"4"}},{"id":4208289,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoiland Jesper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-15T13:13:05.000Z","date":"2017-09-15","kind":"purchase","acquired":true,"shares":6100,"price":32.7227,"value":199608.47,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were  purchased in multiple transactions at prices ranging from $32.688 to $32.7387, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Common Stock purchased at each separate price."}],"balance_after":6100,"source":{"system":"sec-edgar","filing":"0001209191-17-052911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919117052911/doc4.xml","form_type":"4"}},{"id":4255254,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":48341,"kind":"person","name":"Hoeiland Jesper","position":1,"cik":"0001711694","reported_name":"Hoiland Jesper","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-18T16:52:22.000Z","date":"2017-07-17","kind":"grant","acquired":true,"shares":305000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on July 17, 2018 and the remaining shares shall vest in substantially equal monthly installments over the following three years."}],"balance_after":305000,"derivative":{"exercise_price":42.97,"expiration_date":"2027-07-17","underlying":"Common Stock","underlying_shares":305000},"source":{"system":"sec-edgar","filing":"0001209191-17-045520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919117045520/doc4.xml","form_type":"4"}}]}